Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-06

Clinical Trial Update: Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tamoxifen, ovarian ablation, and/or combination chemotherapy in premenopausal women with stage I–III invasive breast cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ovarian ablation
  • Tamoxifen (tamoxifen)

Snippet

Sponsor: Scottish Cancer Therapy Network | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED